Circulating microRNA expression profile: A novel potential predictor for chronic nervous lesions

Acta Biochimica et Biophysica Sinica

Volumn 46, Issue 11, 2014, Pages 942-949

  Xu, Yongming ^a   Zhang, Xin ^a   Pu, Shaofeng ^a   Wu, Junzhen ^a   Lv, Yingying ^a   Du, Dongping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Circulating microRNA; Neuropathic pain; Predictor; Spinal nerve ligation

Indexed keywords

AUTACOID; CYTOKINE; MICRORNA;

ANIMAL; BLOOD; CHRONIC PAIN; GENE EXPRESSION PROFILING; GENETICS; INJURIES; MALE; NEURALGIA; RAT; SPINAL NERVE; SPRAGUE DAWLEY RAT;

ANIMALS; CHRONIC PAIN; CYTOKINES; GENE EXPRESSION PROFILING; INFLAMMATION MEDIATORS; MALE; MICRORNAS; NEURALGIA; RATS; RATS, SPRAGUE-DAWLEY; SPINAL NERVES;

EID: 84911428575     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmu090     Document Type: Article

References (49)

1. Myers RR, CampanaWMand Shubayev VI. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov Today 2006, 11: 8-20.
2. Ciaramitaro P, Mondelli M, Logullo F, Grimaldi S, Battiston B, Sard A and Scarinzi C, et al. Traumatic peripheral nerve injuries: epidemiological findings, neuropathic pain and quality of life in 158 patients. J Peripher Nerv Syst 2010, 15: 120-127.
3. Parkitny L, McAuley JH, Di Pietro F, Stanton TR, OConnell NE, Marinus J and van Hilten JJ, et al. Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurology 2013, 80: 106-117.
4. Huttenhofer A and Schattner P. The principles of guiding by RNA: chimeric RNA-protein enzymes. Nat Rev Genet 2006, 7: 475-482.
5. Mattick JS. RNA regulation: a new genetics? Nat Rev Genet 2004, 5: 316-323.
6. von Hehn CA, Baron R and Woolf CJ. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 2012, 73: 638-652.
7. Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B and Kelnar K, et al. Identification of miRNA changes in Alzheimers disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 2008, 14: 27-41.
8. Ajit SK. Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors (Basel) 2012, 12: 3359-3369.
9. Machida A, Ohkubo T and Yokota T. Circulating microRNAs in the cerebrospinal fluid of patients with brain diseases. Methods Mol Biol 2013, 1024: 203-209.
10. Orlova IA, Alexander GM, Qureshi RA, Sacan A, Graziano A, Barrett JE and Schwartzman RJ, et al. MicroRNA modulation in complex regional pain syndrome. J Transl Med 2011, 9: 195.
11. Weiland M, Gao XH, Zhou L and Mi QS. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol 2012, 9: 850-859.
12. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K and Guo J, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18: 997-1006.
13. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova- Agadjanyan EL and Peterson A, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105: 10513-10518.
14. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ and Galas DJ, et al. The microRNA spectrum in 12 body fluids. Clin Chem 2010, 56: 1733-1741.
15. Scholer N, Langer C, Dohner H, Buske C and Kuchenbauer F. Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature. Exp Hematol 2010, 38: 1126-1130.
16. Jackson DB. Serum-based microRNAs: are we blinded by potential? Proc Natl Acad Sci USA 2009, 106: E5.
17. Chaplan SR, Bach FW, Pogrel JW, Chung JM and Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53: 55-63.
18. Kim SH and Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50: 355-363.
19. Pu S, Xu Y, Du D, Yang M, Zhang X, Wu J and Jiang W. Minocycline attenuates mechanical allodynia and expression of spinal NMDA receptor 1 subunit in rat neuropathic pain model. J Physiol Biochem 2013, 69: 349-357.
20. Wu J, Xu Y, Pu S, Jiang W and Du D. p38/MAPK inhibitor modulates the expression of dorsal horn GABA(B) receptors in the spinal nerve ligation model of neuropathic pain. Neuroimmunomodulation 2011, 18: 150-155.
21. Dyrskjot L, Zieger K, Kruhoffer M, Thykjaer T, Jensen JL, Primdahl H and Aziz N, et al. A molecular signature in superficial bladder carcinoma predicts clinical outcome. Clin Cancer Res 2005, 11: 4029-4036.
22. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N and Braisted J, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34: 374-378.
23. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT and Barbisin M, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005, 33: e179.
24. Tang F, Hajkova P, Barton SC, Lao K and Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006, 34: e9.
25. Kroh EM, Parkin RK, Mitchell PS and Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010, 50: 298-301.
26. Uceyler N, Rogausch JP, Toyka KV and Sommer C. Differential expression of cytokines in painful and painless neuropathies. Neurology 2007, 69: 42-49.
27. Kusuda R, Cadetti F, Ravanelli MI, Sousa TA, Zanon S, De Lucca FL and Lucas G. Differential expression of microRNAs in mouse pain models. Mol Pain 2011, 7: 17.
28. Zhao J, Lee MC, Momin A, Cendan CM, Shepherd ST, Baker MD and Asante C, et al. Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds. J Neurosci 2010, 30: 10860-10871.
29. Favereaux A, Thoumine O, Bouali-Benazzouz R, Roques V, Papon MA, Salam SA and Drutel G, et al. Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR-103: role in pain. EMBO J 2011, 30: 3830-3841.
30. Peng X, Gralinski L, Armour CD, Ferris MT, Thomas MJ, Proll S and Bradel-Tretheway BG, et al. Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signaling. mBio 2010, 1: e00206-e00210.
31. Bredy TW, Lin Q, Wei W, Baker-Andresen D and Mattick JS. MicroRNA regulation of neural plasticity and memory. Neurobiol Learn Mem 2011, 96: 89-94.
32. Cho WC. Exploiting the therapeutic potential of microRNAs in human cancer. Expert Opin Ther Targets 2012, 16: 345-350.
33. Ponomarev ED, Veremeyko T and Weiner HL. MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia 2013, 61: 91-103.
34. Parsons MJ, Grimm CH, Paya-Cano JL, Sugden K, Nietfeld W, Lehrach H and Schalkwyk LC. Using hippocampal microRNA expression differences between mouse inbred strains to characterise miRNA function. Mamm Genome 2008, 19: 552-560.
35. Uceyler N and Sommer C. Cytokine regulation in animal models of neuropathic pain and in human diseases. Neurosci Lett 2008, 437: 194-198.
36. Angst MS, Phillips NG, Drover DR, Tingle M, Ray A, Swan GE and Lazzeroni LC, et al. Pain sensitivity and opioid analgesia: a pharmacogenomic twin study. Pain 2012, 153: 1397-1409.
37. Hocking LJ, Generation S, Morris AD, Dominiczak AF, Porteous DJ and Smith BH. Heritability of chronic pain in 2195 extended families. Eur J Pain 2012, 16: 1053-1063.
38. Nielsen CS, Knudsen GP and Steingrimsdottir OA. Twin studies of pain. Clin Genet 2012, 82: 331-340.
39. Mogil JS. Pain genetics: past, present and future. Trends Genet 2012, 28: 258-266.
40. Wu M, Jolicoeur N, Li Z, Zhang L, Fortin Y, LAbbe D and Yu Z, et al. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis 2008, 29: 1710-1716.
41. Coassin S, Brandstatter A and Kronenberg F. Lost in the space of bioinformatic tools: a constantly updated survival guide for genetic epidemiology. The GenEpi Toolbox. Atherosclerosis 2010, 209: 321-335.
42. Bai G, Ambalavanar R, Wei D and Dessem D. Downregulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain. Mol Pain 2007, 3: 15.
43. Ali Z, Ringkamp M, Hartke TV, Chien HF, Flavahan NA, Campbell JN and Meyer RA. Uninjured C-fiber nociceptors develop spontaneous activity and alpha-adrenergic sensitivity following L6 spinal nerve ligation in monkey. J Neurophysiol 1999, 81: 455-466.
44. von Schack D, Agostino MJ, Murray BS, Li Y, Reddy PS, Chen J and Choe SE, et al. Dynamic changes in the microRNA expression profile reveal multiple regulatory mechanisms in the spinal nerve ligation model of neuropathic pain. PLoS One 2011, 6: e17670.
45. Kim SW, Hayashi M, Lo JF, Yang Y, Yoo JS and Lee JD. ADP-ribosylation factor 4 small GTPase mediates epidermal growth factor receptor-dependent phospholipase D2 activation. J Biol Chem 2003, 278: 2661-2668.
46. Mercatelli N, Coppola V, Bonci D, Miele F, Costantini A, Guadagnoli M and Bonanno E, et al. The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS ONE 2008, 3: e4029.
47. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafre SA and Farace MG. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 2007, 282: 23716-23724.
48. Liu X, He M, Hou Y, Liang B, Zhao L, Ma S and Yu Y. Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma. Oncol Rep 2013, 29: 1415-1420.
49. Poh KW, Yeo JF and Ong WY. MicroRNA changes in the mouse prefrontal cortex after inflammatory pain. Eur J Pain 2011, 15: e1-e12.